NSE (ENO2) is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. It is highly expressed in neurons, neuroendocrine cells, and tumors of neural origin, making it a critical biomarker for neuronal injury and neuroendocrine malignancies .
| Property | Details |
|---|---|
| Molecular Weight | ~47–50 kDa |
| Isoforms | Alpha (ENO1), Beta (ENO3), Gamma (ENO2/NSE) |
| Function | Glycolysis, neuroprotection, and neurotrophic support |
| Tissue Specificity | Neurons, peripheral nerves, neuroendocrine cells |
NSE antibodies are widely used in research and diagnostics. Key applications include:
Immunohistochemistry (IHC): Identification of neuronal and neuroendocrine cells in tissue sections .
Western Blot (WB): Detection of NSE in lysates from brain or tumor samples .
Immunofluorescence (IF): Localization of NSE in cultured neurons .
Biomarker Assays: Quantification of NSE in cerebrospinal fluid (CSF) or serum to assess neuronal damage .
Host Species: Rabbit
Applications: IHC, WB, ELISA
Specificity: Binds to gamma-enolase (ENO2); does not cross-react with alpha/beta isoforms .
NSE levels in blood/CSF correlate with neuronal damage in stroke, traumatic brain injury, and neurodegenerative diseases .
Overexpression of NSE is observed in small-cell lung carcinoma and neuroblastoma, aiding in tumor diagnosis .
Antibodies against NSE are often used alongside synaptophysin and chromogranin A for neuroendocrine tumor profiling .
KEGG: spo:SPAC11E3.08c
STRING: 4896.SPAC11E3.08c.1
Nse6 is a non-essential nuclear protein that forms a heterodimer with Nse5 (Nse5/6), which plays a critical role in DNA repair as part of the Smc5-Smc6 holocomplex (Smc5/6). The Nse5/6 dimer specifically facilitates DNA repair roles and is particularly important for the response to genotoxic agents that block replication fork progression. Mutations in Nse5/6 result in high levels of spontaneous DNA damage and mitotic catastrophe in the absence of checkpoint regulators like Rad3 . Research targeting Nse6 is valuable for understanding fundamental DNA repair mechanisms, chromosome segregation, and genome integrity maintenance.
Nse6 antibodies specifically target the Nse6 protein, which forms an obligate heterodimer with Nse5. Unlike antibodies targeting core Smc5/6 components that may disrupt essential cellular functions, Nse6 antibodies allow researchers to study a non-essential but functionally important component of the complex. This provides a unique opportunity to investigate the DNA repair roles of the Smc5/6 complex without completely compromising cell viability. The specificity of Nse6 antibodies enables researchers to distinguish between the various non-SMC elements (Nse1-6) in the complex, which is crucial for dissecting their individual contributions to DNA repair mechanisms .
Based on research practices with similar proteins in the Smc5/6 complex, Nse6 antibodies are commonly used in several techniques:
Immunoprecipitation (IP) - To isolate Nse6-containing complexes from cell lysates
Western blotting - To detect and quantify Nse6 protein expression
Chromatin immunoprecipitation (ChIP) - To identify genomic regions where Nse6 binds
Immunofluorescence microscopy - To visualize the subcellular localization of Nse6
For example, in studies involving similar components of the Smc5/6 complex, TAP-tagged proteins from genomic loci were purified from clarified lysates and analyzed using methods like MudPIT (Multidimensional Protein Identification Technology) .
Based on structural studies, the Rtt107-Interacting Motif (RIM) region of Nse6, particularly residues 17-41, contains important functional domains that could serve as effective epitopes. Within this region, two key sections have been identified:
Nse6 RIM-N region (N-terminal portion): Contains critical residues D17, S18, and Q19 that form an electrostatic interface with Rtt107 NTD
Nse6 RIM-C region (residues 23-41): Forms hydrophobic contacts, with F36 being particularly important as it embeds in a hydrophobic pocket of interacting proteins
Antibodies targeting these regions would be valuable for studying protein-protein interactions involving Nse6, particularly its association with Rtt107 and other components of the DNA repair machinery.
To ensure antibody specificity, researchers should implement a multi-faceted validation approach:
Positive controls: Test antibody reactivity against recombinant Nse6 protein or in cells overexpressing tagged Nse6
Negative controls: Verify absence of signal in Nse6 knockout/knockdown samples
Immunoprecipitation followed by mass spectrometry: Confirm that the antibody pulls down Nse6 and known interacting partners like Nse5
Mutant validation: Test antibody against samples containing Nse6 with mutations in the antibody epitope region, such as the DSQ 17-19 motif (Nse6 RIM) that is critical for interaction with Rtt107
Cross-reactivity assessment: Evaluate potential cross-reactivity with other Smc5/6 complex components
When using Nse6 antibodies across different model organisms, researchers should consider:
Sequence conservation: While Nse6 functions are conserved, primary sequences may vary. For example, budding yeast homologs like KRE29 share functional similarity with fission yeast Nse6 despite limited sequence conservation .
Species-specific validation: Always validate antibodies for cross-reactivity with the specific species being studied.
Control experiments: Include appropriate controls for each model organism, especially when using antibodies developed against Nse6 from a different species.
Alternative approaches: Consider using epitope tagging in model organisms where antibodies show limited cross-reactivity.
Nse5/6 has been implicated in suppressing recombination that results in Holliday junction formation or in Holliday junction resolution. Researchers can use Nse6 antibodies to investigate these processes through:
ChIP-seq experiments: Map Nse6 localization at sites of replication fork stalling or DNA damage
Co-immunoprecipitation assays: Identify interactions between Nse6 and other factors involved in Holliday junction metabolism, such as Mus81 and Rqh1 (hBLM)
Immunofluorescence microscopy: Track Nse6 recruitment to sites of DNA damage in wild-type cells versus cells with mutations in the homologous recombination machinery (e.g., Rhp51/Rad51 mutants)
Proximity ligation assays: Detect in situ interactions between Nse6 and components of the Holliday junction resolution machinery
The viability of Nse6 mutants depends on factors that resolve or prevent Holliday junction formation, suggesting a key role in this process .
To study Nse6 interactions with the Smc5/6 complex:
Sequential immunoprecipitation: Use Nse6 antibodies followed by antibodies against other Smc5/6 components to isolate specific subcomplexes
Proximity-dependent biotin identification (BioID): Fuse biotin ligase to Nse6 to identify proximal proteins within the complex
Chemical crosslinking coupled with mass spectrometry: Map interaction interfaces between Nse6 and other components of the Smc5/6 complex
Structural studies: Use Nse6 antibodies to facilitate cryo-EM or X-ray crystallography studies of the Smc5/6 complex
Mutational analysis: Compare immunoprecipitation results using antibodies against wild-type Nse6 versus mutants like Nse6 RIM to understand the architecture of the complex
Nse5/6 mutants display hypersensitivity to replication fork blockage induced by DNA alkylation or UV lesions . To investigate this role:
Chromatin fractionation: Use Nse6 antibodies to detect chromatin association of Nse6 after replication stress
iPOND (isolation of Proteins On Nascent DNA): Combine with Nse6 antibodies to examine recruitment to stalled replication forks
DNA fiber analysis: Correlate Nse6 localization with replication fork progression and restart
Electron microscopy: Use immunogold-labeled Nse6 antibodies to visualize Nse6 at replication structures
ChIP-seq after replication stress: Map genome-wide association of Nse6 at sites of replication stress
Based on similar studies with Smc5/6 complex components, a recommended immunoprecipitation protocol would include:
Cell lysis: Harvest cells and lyse in buffer A (50 mM Tris [pH 8], 150 mM NaCl, 2 mM EDTA, 10% glycerol, 0.2% Nonidet P-40, protease inhibitors including 5 μg each of leupeptin, pepstatin, and aprotinin/ml, 1 mM PMSF)
Clarification: Centrifuge lysate at high speed to remove cellular debris
Pre-clearing: Incubate clarified lysate with protein A/G beads to reduce non-specific binding
Antibody binding: Add Nse6 antibody (typically 2-5 μg) to the pre-cleared lysate and incubate overnight at 4°C
Immunoprecipitation: Add protein A/G beads and incubate for 2-3 hours at 4°C
Washing: Wash beads 4-5 times with buffer A
Elution: Elute bound proteins using SDS sample buffer or a specific elution buffer depending on downstream applications
Analysis: Analyze by Western blotting, mass spectrometry, or other applicable methods
When encountering weak or non-specific signals:
Antibody concentration optimization: Test a range of primary antibody dilutions (e.g., 1:500 to 1:5000)
Blocking optimization: Try different blocking reagents (BSA, milk, commercial blockers) and concentrations
Incubation conditions: Adjust temperature (4°C, room temperature) and duration (1 hour to overnight)
Stringency adjustment: Modify salt concentration or detergent levels in wash buffers
Epitope retrieval: For fixed samples, optimize antigen retrieval methods
Cross-linking consideration: If using a cross-linking approach, test different cross-linkers and concentrations
Sample preparation: Ensure protein denaturation is complete for Western blotting applications
Controls: Always include positive and negative controls to benchmark signal specificity
For studying protein-protein interactions:
Gentle lysis conditions: Use mild detergents (0.1-0.5% NP-40 or Triton X-100) to preserve protein complexes
Co-immunoprecipitation: Validate interactions identified in mass spectrometry by targeted co-IP experiments
Reciprocal co-IP: Confirm interactions by performing IP with antibodies against both Nse6 and its potential interacting partners
Mutagenesis: Use mutants like Nse6 RIM that disrupt specific interactions as negative controls
Native vs. denatured conditions: Compare results under native and denaturing conditions to distinguish direct from indirect interactions
Crosslinking: Consider using reversible crosslinking agents to stabilize transient interactions
Buffer optimization: Test different buffer compositions to preserve specific interactions of interest
Developing specific Nse6 antibodies faces several challenges:
Sequence conservation issues: Limited sequence conservation across species despite functional conservation
Complex formation: Nse6 exists primarily in complex with Nse5 and other Smc5/6 components, potentially masking epitopes
Conformational epitopes: Important functional regions may form conformational epitopes difficult to mimic with peptide antigens
Post-translational modifications: Potential PTMs might affect antibody recognition
Cross-reactivity: Possible cross-reactivity with other ARM/HEAT repeat proteins, as Nse6 belongs to this protein family
Nse6 antibodies can advance cancer research through:
Biomarker development: Assess Nse6 expression or localization changes in cancer cells with genomic instability
Therapeutic target validation: Study Nse6 functions that could be targeted to sensitize cancer cells to DNA-damaging therapies
Synthetic lethality screening: Identify cancer-specific vulnerabilities related to Nse6 function
Patient stratification: Determine if Nse6 expression/localization patterns correlate with treatment response
Fundamental mechanisms: Investigate how Nse6 dysfunction contributes to genomic instability, a hallmark of cancer
Emerging technologies that could enhance Nse6 antibody applications include:
Single-cell proteomics: Analyze Nse6 expression and localization at the single-cell level
Super-resolution microscopy: Visualize Nse6 localization at DNA repair sites with nanometer precision
CRISPR epitope tagging: Generate endogenously tagged Nse6 for improved antibody recognition
Intrabodies: Develop antibody fragments for tracking Nse6 in living cells
Nanobodies: Create small single-domain antibodies with enhanced access to structural epitopes
Spatial proteomics: Map the subcellular distribution of Nse6 and interacting partners
Antibody engineering: Develop recombinant antibodies with improved specificity and affinity for Nse6-specific epitopes